Our data showed that depletion of MFRN2 and of proteins of the mitochondrial ISC machinery confers cell resistance to effector caspase activation by an apoptotic treatment like STS, as demonstrated previously with cancer cells grown under hypoxic conditions [20]. The gene discussed is SLC25A28; the disease is cancer.